146 related articles for article (PubMed ID: 38393411)
21. Apatinib Inhibits Stem Properties and Malignant Biological Behaviors of Breast Cancer Stem Cells by Blocking Wnt/β-catenin Signal Pathway through Downregulating LncRNA ROR.
Jiang B; Zhu H; Tang L; Gao T; Zhou Y; Gong F; Tan Y; Xie L; Wu X; Li Y
Anticancer Agents Med Chem; 2022; 22(9):1723-1734. PubMed ID: 33845750
[TBL] [Abstract][Full Text] [Related]
22. Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/β-catenin negative feedback loop.
Mukherjee S; Mazumdar M; Chakraborty S; Manna A; Saha S; Khan P; Bhattacharjee P; Guha D; Adhikary A; Mukhjerjee S; Das T
Stem Cell Res Ther; 2014 Oct; 5(5):116. PubMed ID: 25315241
[TBL] [Abstract][Full Text] [Related]
23. A novel oncogenic role of inositol phosphatase SHIP2 in ER-negative breast cancer stem cells: involvement of JNK/vimentin activation.
Fu CH; Lin RJ; Yu J; Chang WW; Liao GS; Chang WY; Tseng LM; Tsai YF; Yu JC; Yu AL
Stem Cells; 2014 Aug; 32(8):2048-60. PubMed ID: 24802135
[TBL] [Abstract][Full Text] [Related]
24. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.
Han M; Liu M; Wang Y; Mo Z; Bi X; Liu Z; Fan Y; Chen X; Wu C
Mol Cell Biochem; 2012 Apr; 363(1-2):427-36. PubMed ID: 22187223
[TBL] [Abstract][Full Text] [Related]
25. Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer.
Zhang L; Xu L; Zhang F; Vlashi E
Cell Cycle; 2017 Apr; 16(8):737-745. PubMed ID: 27753527
[TBL] [Abstract][Full Text] [Related]
26. MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells.
Zhao Y; Li Y; Lou G; Zhao L; Xu Z; Zhang Y; He F
PLoS One; 2012; 7(6):e39102. PubMed ID: 22723937
[TBL] [Abstract][Full Text] [Related]
27. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
28. The metabolic regulator ERRα, a downstream target of HER2/IGF-1R, as a therapeutic target in breast cancer.
Chang CY; Kazmin D; Jasper JS; Kunder R; Zuercher WJ; McDonnell DP
Cancer Cell; 2011 Oct; 20(4):500-10. PubMed ID: 22014575
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the stemness potency of
Yousefnia S; Ghaedi K; Seyed Forootan F; Nasr Esfahani MH
Tumour Biol; 2019 Aug; 41(8):1010428319869101. PubMed ID: 31423948
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of ERRα inhibits angiogenesis in human umbilical vein endothelial cells through regulating VEGF production and PI3K/Akt/STAT3 signaling pathway.
Zhang LD; Chen L; Zhang M; Qi HJ; Chen L; Chen HF; Zhong MK; Shi XJ; Li QY
Eur J Pharmacol; 2015 Dec; 769():167-76. PubMed ID: 26586335
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells.
Shiraishi A; Tachi K; Essid N; Tsuboi I; Nagano M; Kato T; Yamashita T; Bando H; Hara H; Ohneda O
Cancer Sci; 2017 Mar; 108(3):362-372. PubMed ID: 28012234
[TBL] [Abstract][Full Text] [Related]
32. Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines.
Gonçalves Ndo N; Colombo J; Lopes JR; Gelaleti GB; Moschetta MG; Sonehara NM; Hellmén E; Zanon Cde F; Oliani SM; Zuccari DA
PLoS One; 2016; 11(3):e0150407. PubMed ID: 26934679
[TBL] [Abstract][Full Text] [Related]
33. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
34. Estrogen-related receptor α participates transforming growth factor-β (TGF-β) induced epithelial-mesenchymal transition of osteosarcoma cells.
Chen Y; Zhang K; Li Y; He Q
Cell Adh Migr; 2017 Jul; 11(4):338-346. PubMed ID: 27532429
[TBL] [Abstract][Full Text] [Related]
35. Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition.
Chen JH; Kuo KT; Bamodu OA; Lin YC; Yang RB; Yeh CT; Chao TY
Exp Cell Res; 2018 Sep; 370(2):444-453. PubMed ID: 29981340
[TBL] [Abstract][Full Text] [Related]
36. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
[TBL] [Abstract][Full Text] [Related]
37. Gemcitabine and XCT790, an ERRα inverse agonist, display a synergistic anticancer effect in pancreatic cancer.
Liu SL; Liang HB; Yang ZY; Cai C; Wu ZY; Wu XS; Dong P; Li ML; Zheng L; Gong W
Int J Med Sci; 2022; 19(2):286-298. PubMed ID: 35165514
[TBL] [Abstract][Full Text] [Related]
38. Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs.
Mandal S; Arfuso F; Sethi G; Dharmarajan A; Warrier S
Int J Biochem Cell Biol; 2019 May; 110():59-69. PubMed ID: 30735730
[TBL] [Abstract][Full Text] [Related]
39. Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways.
Cruz-Lozano M; González-González A; Marchal JA; Muñoz-Muela E; Molina MP; Cara FE; Brown AM; García-Rivas G; Hernández-Brenes C; Lorente JA; Sanchez-Rovira P; Chang JC; Granados-Principal S
Eur J Nutr; 2019 Dec; 58(8):3207-3219. PubMed ID: 30460610
[TBL] [Abstract][Full Text] [Related]
40. Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2-mediated pathway in breast cancer.
Balakrishnan S; Bhat FA; Raja Singh P; Mukherjee S; Elumalai P; Das S; Patra CR; Arunakaran J
Cell Prolif; 2016 Dec; 49(6):678-697. PubMed ID: 27641938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]